Skip to content
OpenCapital
Get started

ADMA Biologics ADMA ADMA Bio Manufacturing — Cost Of Revenue

Other segment segments

Plasma Collection Centers
$793K+22.4%

Similar metrics at other companies

Chemours logo
CCAdvanced Performance Materials — Cost Of Revenue
$238M-4.8%
Veracyte logo
VCYTBiopharmaceutical and other revenue — Cost of Revenue
$8K-99.7%
ALM
ALMRProduct — Cost Of Revenue
$9.81M+82.6%
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Cost of revenues
$4.76B+7.9%
Pfizer logo
PFEBiopharma — Cost of Sales
$3.03B+31.1%
Idexx Laboratories logo
IDXXProduct revenue — Cost of revenue
$194.43M+10.8%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — cost of revenue?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — cost of revenue of $32.95M in Q1 2026.
How has ADMA Biologics's ADMA bio manufacturing — cost of revenue changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — cost of revenue decreased by 37.9% year-over-year, from $53.06M to $32.95M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — cost of revenue?
Over 3 years (2022 to 2025), ADMA Biologics's ADMA bio manufacturing — cost of revenue has grown at a 22.4% compound annual growth rate (CAGR), from $108.88M to $199.86M.
What does ADMA bio manufacturing — cost of revenue mean?
Includes the direct costs attributable to the production of plasma-derived biologics, such as raw materials, direct labor, and manufacturing overhead. Monitoring this metric is essential for assessing the production efficiency and gross margin stability of the manufacturing segment.